Hanmi Pharmaceutical Stock Falls 14% on July 29 Despite Q2 Earnings Beat, Mainland China Unit Slumps 96.6%
According to the Korea Exchange, Hanmi Pharmaceutical's stock fell 14% on July 29 (closing at 322,000 KRW) and declined an additional 4.1% the prior day, totaling a 17.54% drop over two days despite the company's second-quarter earnings beat.
Hanmi reported Q2 operating profit of 131 billion KRW, e
Hanmi Pharmaceutical-3.26%
GateNews·17h ago
